Shanghai Fochon Pharmaceutical Co., Ltd.

Fochon Pharmaceuticals, Ltd.

Chongqing Fochon Pharmaceutical Co., Ltd.

Chinese Academy of Sciences

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Fochon Biosciences, Ltd.

Fochon Pharmaceutical Co., Ltd.

Xianlong Wang

Weibo Wang

Xingdong Zhao

Zuwen Zhou

Jing Sun

Yanxin Liu

Lihua Jiang

Haohan Tan

Tongshuang Li

Zhifang Chen

Zhifu Li

Ling Chen

Rui Tan

Qihong Liu

Yue Rong

Qiang Tian

Lijun Yang

Min Lin

Huajie Zhang

Li Linghu

Fanxin Zeng

Weipeng Zhang

Hongbin Liu

Chengxi He

Zongyao Zou

Bin Liu

Kai Ran

Quan Yuan

Hailong Shi

Bo Fang

Jiemin Fu

Chuiliang Yu

Jian Ding

Meiyu Geng

Linghua Meng

Shu Lin

Yuwei Gao

Provided are certain Bcl-2 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

Apoptosis-inducing agents

Provided are certain TRK inhibitors of formula (I): pharmaceutical compositions thereof, and methods of use thereof.

Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors

Provided are certain URAT1 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Indolizine derivatives, composition and methods of use

Certain CDK4/6 inhibitors and pharmaceutically acceptable salts thereof are described. In particular, these compounds can inhibit kinase activity of CDK4/6 and may be useful for the treatment of hyper-proliferative diseases like cancer and inflammation. In addition, the pharmaceutical compositions thereof and methods of use thereof are also described.

Certain protein kinase inhibitors

Provided are certain compounds or pharmaceutically acceptable salts thereof which can inhibit kinase activity of Bruton's tyrosine kinase (BTK) and may be useful for the treatment of diseases like cancer, immunological disease and inflammation.

Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors

Provided are certain CDK4/6 inhibitors with the structure of formula (I), pharmaceutical compositions thereof, and methods of use therefor. The compounds are of the class of pyrimidin-2 amine derivatives, useful for the treatment of hyper-proliferative diseases. 

Certain protein kinase inhibitor

Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Provided are compound of formula (I) as certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use thereof. 

Disclosed herein are protein kinase inhibitors, more particularly novel quinazoline derivatives and pharmaceutical compositions thereof, and method of use thereof.

Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.

Growing community of inventors

Chongqing, China

Xianlong Wang